An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents (Q46066669)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents |
scientific article |
Statements
1 reference
An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents (English)
1 reference
Arthur Kavanaugh
1 reference
Mark C Genovese
1 reference
Michael E Weinblatt
1 reference
Charles Peterfy
1 reference
Michael L White
1 reference
Maryann O'Brien
1 reference
Elliott B Grossbard
1 reference
Daniel B Magilavy
1 reference
1 February 2011
1 reference
63
1 reference
2
1 reference
337-345
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference